Armata Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.76M, a 5.61% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$41.5M, a 0.39% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$40.9M, a 10.7% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$36.9M, a 55.1% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$23.8M, a 10.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$41.5M -$9.76M +$580K +5.61% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$42.1M -$11.9M -$2.29M -23.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$39.8M -$10.2M +$1.12M +9.85% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$40.9M -$9.58M +$749K +7.25% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$41.6M -$10.3M -$1.71M -19.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$39.9M -$9.63M -$409K -4.44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$39.5M -$11.3M -$2.57M -29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$36.9M -$10.3M -$4.28M -70.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$32.7M -$8.62M -$2.48M -40.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$30.2M -$9.22M -$3.02M -48.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$27.2M -$8.78M -$3.34M -61.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$23.8M -$6.05M +$405K +6.28% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$24.2M -$6.14M -$520K -9.25% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$23.7M -$6.2M -$1.61M -35% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$22.1M -$5.44M -$514K -10.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$21.6M -$6.45M -$2.08M -47.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$19.5M -$5.62M +$1.15M +17% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$20.7M -$4.59M +$568K +11% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$21.2M -$4.92M -$1.48M -43% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$19.8M -$4.38M +$4.96M +53.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$24.7M -$6.78M -$4.35M -179% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$20.4M -$5.16M -$2.32M -81.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$18M -$3.44M -$386K -12.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$17.7M -$9.33M -$6.97M -295% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$10.7M -$2.43M -$1.68M -226% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$9.01M -$2.84M +$6.84M +70.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$15.9M -$3.06M +$304K +9.05% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$16.2M -$2.37M +$9.5M +80.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-25
Q3 2017 -$25.7M -$746K +$2.66M +78.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$28.3M -$9.69M -$6.1M -170% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$22.2M -$3.36M +$1.16M +25.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$23.4M -$11.9M -$8.92M -304% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-27
Q3 2016 -$14.5M -$3.41M -$979K -40.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$13.5M -$3.59M -$997K -38.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$12.5M -$4.52M -$2.25M -99.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$10.2M -$2.94M -$343K -13.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-27
Q3 2015 -$9.88M -$2.43M +$2.8M +53.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-27
Q2 2015 -$12.7M -$2.59M +$1.16M +30.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-27
Q1 2015 -$13.8M -$2.27M +$267K +10.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-27
Q4 2014 -$14.1M -$2.6M -$11K -0.43% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$14.1M -$5.23M -$2.89M -123% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$11.2M -$3.75M +$2.38M +38.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$13.6M -$2.53M -$1.2M -90.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
Q4 2013 -$12.4M -$2.59M Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$2.34M Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-04-15
Q2 2013 -$6.12M Apr 1, 2013 Jun 30, 2013 10-Q/A 2015-04-15
Q1 2013 -$1.33M Jan 1, 2013 Mar 31, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.